Evonik is expanding its full service offering to the cosmetics industry with pending acquisition of cosmetics specialist, Dr. Straetmans. Based in Hamburg, Germany, the company specialises in developing and marketing alternative preservatives for the cosmetics industry.
The move allows Evonik to complement the broad specialties portfolio of its cosmetics business and to further consolidate its position as a leading global partner for the cosmetics industry. The transaction is subject to approval by the relevant antitrust authorities. It is expected to be finalised during the first half of 2017, and contracting parties have agreed not to disclose the purchase price.
An intelligent fit
‘Dr. Straetmans is a perfect match for us, both strategically and culturally. We intend to develop the company’s business globally beyond its existing markets in Europe and the United States,’ says Hans-Josef Ritzert, member of the management board of Evonik Nutrition & Care.
The company employs over 60 people, and will continue to operate as a legal entity. Dr. Straetmans’ Hamburg site will become Evonik’s global competence centre for preservative solutions.
‘Our aim is to offer cosmetics manufacturers new solutions enabling them to distinguish themselves from the competition,’ says Tammo Boinowitz, who heads the personal care business line at Evonik. ‘In the future, we will be able to offer complete formulation systems, including preservation. In doing so, we make an important contribution to optimising our customers’ development work.’
More than the alternative
Established in 1984, Dr. Straetmans is a pioneer in alternative preservative systems. The difference between these systems and conventional preservatives is that their functionality in a finished product goes beyond preservation. For example, they offer additional moisturisation. However, the use of alternative preservative systems is complex.
‘The reason for this is that we’re introducing larger amounts of surface active ingredients into the formulation. Our competencies in areas such as application and formulation allow us to maintain a stable emulsion,’ explains Jan Jänichen, MD Dr. Straetmans.
Wilfried Petersen, joint MD of Dr. Straetmans, adds: ‘In combination with Evonik’s emulsifier expertise, we can provide our customers with even better support for developing formulations.’
In addition to its alternative preservative systems, Dr. Straetmans offers selected conventional preservatives. The decades-long experience of both companies and the comprehensive product range mean that in future Evonik and Dr. Straetmans can offer customers formulation concepts for sustainable use.